SEI Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$429K Buy
122,180
+16,544
+16% +$52.9K ﹤0.01% 2708
2025
Q4
$288K Buy
105,636
+76,976
+269% +$178K ﹤0.01% 2764
2025
Q3
$62.2K Buy
28,660
+1,986
+7% +$4.69K ﹤0.01% 2762
2025
Q2
$45.9K Sell
26,674
-394,433
-94% -$981K ﹤0.01% 2758
2025
Q1
$1.4M Sell
421,107
-57,374
-12% -$296K ﹤0.01% 1772
2024
Q4
$3.54M Buy
478,481
+8,965
+2% +$83.1K ﹤0.01% 1440
2024
Q3
$4.41M Buy
469,516
+184,755
+65% +$1.75M 0.01% 1348
2024
Q2
$2.28M Sell
284,761
-48,387
-15% -$519K ﹤0.01% 1578
2024
Q1
$4.94M Buy
333,148
+84,382
+34% +$982K 0.01% 1225
2023
Q4
$2.02M Sell
248,766
-12,102
-5% -$63.3K ﹤0.01% 1595
2023
Q3
$1.19M Sell
260,868
-89,953
-26% -$587K ﹤0.01% 1828
2023
Q2
$2.47M Buy
350,821
+64,130
+22% +$459K ﹤0.01% 1542
2023
Q1
$1.75M Sell
286,691
-8,331
-3% -$57.5K ﹤0.01% 1680
2022
Q4
$1.89M Buy
295,022
+9,041
+3% +$70.6K ﹤0.01% 1527
2022
Q3
$2.74M Sell
285,981
-29,932
-9% -$345K 0.01% 1392
2022
Q2
$3.49M Buy
315,913
+40,901
+15% +$536K 0.01% 1282
2022
Q1
$4.58M Buy
275,012
+8,241
+3% +$127K 0.01% 1148
2021
Q4
$5.09M Buy
266,771
+44,367
+20% +$977K 0.01% 1131
2021
Q3
$5.49M Sell
222,404
-9,219
-4% -$217K 0.01% 1030
2021
Q2
$6.03M Buy
231,623
+10,181
+5% +$265K 0.01% 985
2021
Q1
$7.02M Sell
221,442
-97,085
-30% -$4.02M 0.02% 849
2020
Q4
$14.8M Sell
318,527
-21,847
-6% -$867K 0.04% 466
2020
Q3
$11.2M Sell
340,374
-24,190
-7% -$742K 0.03% 504
2020
Q2
$10M Buy
364,564
+83,439
+30% +$2.74M 0.03% 546
2020
Q1
$8.41M Buy
281,125
+167,861
+148% +$4.45M 0.03% 527
2019
Q4
$3.14M Buy
113,264
+60,537
+115% +$1.38M 0.01% 1129
2019
Q3
$960K Sell
52,727
-12,470
-19% -$276K ﹤0.01% 1617
2019
Q2
$1.6M Buy
65,197
+40,748
+167% +$614K 0.01% 1419
2019
Q1
$233K Buy
+24,449
New +$237K ﹤0.01% 2227
2015
Q4
Sell
-2,100
Closed -$12K 2605
2015
Q3
$12K Buy
+2,100
New +$16.4K ﹤0.01% 2158

Other funds holding IOVA